Status:
COMPLETED
Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting
Lead Sponsor:
Aswan University Hospital
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
2-13 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the difference of the gastric volume by quantitative measurements of gastric antrum preoperatively and postoperatively by using 5mg famotidine versus placebo as a ...
Detailed Description
Gastric ultrasound examinations will be performed preoperatively and postoperatively on patients undergoing emergency surgery in pediatric. Gastric cross-sectional area (CSA) will be measured, in orde...
Eligibility Criteria
Inclusion
- Pediatrics patients aging between 2-13 years .
- pediatrics undergo urgent surgery (i.e., surgery that cannot be postponed for more than 48 h since clinical onset).
- PatientPediatrics come in trauma
Exclusion
- PatientPediatrics severly shocked .
- PatientPediatrics with diffusely distended abdomen as this will obstacle gastric ultrasound .
- PatientPediatrics with history of hypersenstivity to famotidine .
- PatientPediatrics with hepatic or renal impairments
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06211088
Start Date
August 1 2024
End Date
January 30 2025
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zaher
Cairo, Egypt